[EN] HETEROBICYCLIC COMPOUNDS AS HISTAMINE H4-RECEPTOR ANTAGONISTS [FR] COMPOSÉS HÉTÉROBICYCLIQUES UTILES COMME ANTAGONISTES DU RÉCEPTEUR H4 DE L'HISTAMINE
HETEROBICYCLIC COMPOUNDS AS HISTAMINE H4-RECEPTOR ANTAGONISTS
申请人:Raphy Gilles
公开号:US20100298289A1
公开(公告)日:2010-11-25
The present invention concerns heterobicyclic compounds of formula (I) processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
本发明涉及式(I)的杂双环化合物,其制备过程,含有它们的制药组合物以及它们作为药物的用途。
[EN] HETEROBICYCLIC COMPOUNDS AS HISTAMINE H4-RECEPTOR ANTAGONISTS<br/>[FR] COMPOSÉS HÉTÉROBICYCLIQUES UTILES COMME ANTAGONISTES DU RÉCEPTEUR H4 DE L'HISTAMINE
申请人:UCB PHARMA SA
公开号:WO2009047255A1
公开(公告)日:2009-04-16
The present invention concerns heterobicyclic compounds of formula (I) processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.